Pfizer Inc. (NYSE: PFE) today announced positive topline results from its pivotal Phase 3 CREST trial evaluating sasanlimab, an investigational anti-P
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 847999.
Balancing anticancer therapy efficacy and safety in advanced hepatocellular carcinoma: a case report
View this file, and add comments too.
BOULDER, Colo., Jan. 10, 2025 (GLOBE NEWSWIRE) — Foresight Diagnostics, a leader in ultra-sensitive minimal residual disease (MRD) detection technology,…
ASH Clinical News Editor-in-Chief Aaron Gerds, MD, interviews Meletios-Thanos Dimopoulos, MD, at the 66th ASH Annual Meeting and Exposition to discuss his ab…
PURPOSESWOG S1815 was a randomized, open label phase III trial, evaluating gemcitabine, nab-paclitaxel, and cisplatin (GAP) versus gemcitabine and cisplatin (GC) in patients with newly…
Nature Communications – Colorectal cancer has been linked to multiple environmental factors, however, the role of diet remains incompletely understood. Here, the authors complete a…
This guideline covers investigation and management of heart valve disease presenting in adults. It aims to improve quality of life and survival for people with…
This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our…
http://drmcdougall.comEnjoy my provocative interview with Dr. Burkitt during his visit to Loma Linda University in Southern California on May 23, 1990.Dr. De…
